Research advances in chikungunya virus: Epidemiology, pathogenesis, and control.

Shiqin Dai, Hao Li, Shu Li, Xinhua Shao, Xianliang Cheng

Abstract readReview

In one paragraph

Review in One health (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Chikungunya Virus: What a Transfusion Service Needs to Know.Viruses · 2026
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shiqin DaiThe People's Hospital of Longhua, Shenzhen, Guangdong, China.

Hao LiGerman Cancer Research Center (DKFZ) Unit D400, Heidelberg, Germany.

Shu LiDepartment of Vascular Biology, European Center for Angioscience (ECAS), Medical Faculty Mannheim, Heidelberg University, Mannheim 68167, Germany.

Xinhua ShaoCenter for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin, Heilongjiang 150081, China.

Xianliang ChengZigong Academy of Medical Sciences, Zigong First People's Hospital, Zigong, Sichuan 643000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chikungunya virus (CHIKV) is a mosquito-borne RNA virus endemic to tropical regions, where it causes recurrent outbreaks. Transmitted primarily by

Indexed as

Aedes aegyptiAedes albopictusChikungunya virusCHIKVVaccine development

Identifiers

PMID42022458

DOI10.1016/j.onehlt.2026.101413

PMCPMC13098495

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.